GGrantIndex
← Search

Development of a safe and effective topically administered pharmacotherapy to treat acute corneal pain

$295,086R43FY2024EYNIH

Vyluma Inc., Bridgewater NJ

Investigators

View original record on NIH RePORTER →
Development of a safe and effective topically administered pharmacotherapy to treat acute corneal pain · GrantIndex